Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
by
Da Young Lee
in
Biomarkers
/ Cardiovascular disease
/ Diabetes Mellitus, Type 2
/ Diabetes Mellitus, Type 2 - blood
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diseases of the endocrine glands. Clinical endocrinology
/ Humans
/ Kinases
/ Letter
/ Liraglutide
/ Liraglutide - pharmacology
/ Liraglutide - therapeutic use
/ MicroRNAs
/ MicroRNAs - genetics
/ RC648-665
/ Sulfonylurea Compounds
/ Sulfonylurea Compounds - therapeutic use
/ 내과학
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
by
Da Young Lee
in
Biomarkers
/ Cardiovascular disease
/ Diabetes Mellitus, Type 2
/ Diabetes Mellitus, Type 2 - blood
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diseases of the endocrine glands. Clinical endocrinology
/ Humans
/ Kinases
/ Letter
/ Liraglutide
/ Liraglutide - pharmacology
/ Liraglutide - therapeutic use
/ MicroRNAs
/ MicroRNAs - genetics
/ RC648-665
/ Sulfonylurea Compounds
/ Sulfonylurea Compounds - therapeutic use
/ 내과학
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
by
Da Young Lee
in
Biomarkers
/ Cardiovascular disease
/ Diabetes Mellitus, Type 2
/ Diabetes Mellitus, Type 2 - blood
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diseases of the endocrine glands. Clinical endocrinology
/ Humans
/ Kinases
/ Letter
/ Liraglutide
/ Liraglutide - pharmacology
/ Liraglutide - therapeutic use
/ MicroRNAs
/ MicroRNAs - genetics
/ RC648-665
/ Sulfonylurea Compounds
/ Sulfonylurea Compounds - therapeutic use
/ 내과학
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
Journal Article
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
2023
Request Book From Autostore
and Choose the Collection Method
Overview
KCI Citation Count: 0
Publisher
Korean Diabetes Association,Korean Diabetes Association / Daehan Dangnyobyeong Hakoe,대한당뇨병학회
This website uses cookies to ensure you get the best experience on our website.